| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |